Kura Oncology (KURA) Total Debt (2014 - 2026)
Kura Oncology (KURA) reported Total Debt of $9.7 million for Q1 2026, up 1.86% year-over-year from $9.6 million in Q1 2025, and little changed on a QoQ basis from $9.7 million in Q4 2025.
Kura Oncology (KURA) has 13 years of Total Debt data on file, last reported at $9.7 million in Q1 2026.
- Quarterly Total Debt rose 1.86% year-over-year to $9.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (up 1.86% YoY) and the FY2025 annual result came in at $9.7 million, up 1.97% from the prior year.
- Total Debt steadied at $9.7 million in Q1 2026 per KURA's latest filing, from $9.7 million in the prior quarter.
- Across five years, Total Debt topped out at $9.7 million in Q1 2026 and bottomed at $9.2 million in Q4 2022.
- The 5-year median for Total Debt is $9.4 million (2024), against an average of $9.5 million.
- The widest annual swing landed in 2025, when Total Debt rose 2.12%; it then increased 1.86% in 2026.
- Tracing KURA's Total Debt over 5 years: stood at $9.2 million in 2022, then grew by 1.9% to $9.3 million in 2023, then increased by 2.05% to $9.5 million in 2024, then rose by 1.97% to $9.7 million in 2025, then grew by 0.39% to $9.7 million in 2026.
- Per Business Quant, the three latest KURA Total Debt figures stand at $9.7 million (Q1 2026), $9.7 million (Q4 2025), and $9.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 9.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.75 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 9.67 Mn |
| Jun 30, 2025 | 9.62 Mn |
| Mar 31, 2025 | 9.57 Mn |
| Dec 31, 2024 | 9.52 Mn |
| Sep 30, 2024 | 9.47 Mn |
| Jun 30, 2024 | 9.42 Mn |
| Mar 31, 2024 | 9.38 Mn |
| Dec 31, 2023 | 9.33 Mn |
| Sep 30, 2023 | 9.29 Mn |
| Jun 30, 2023 | 9.24 Mn |
| Mar 31, 2023 | 9.20 Mn |
| Dec 31, 2022 | 9.16 Mn |
| Mar 31, 2021 | 6.50 Mn |
| Dec 31, 2020 | 7.25 Mn |
| Sep 30, 2020 | 7.50 Mn |
| Jun 30, 2020 | 7.50 Mn |
| Mar 31, 2020 | 7.50 Mn |
| Dec 31, 2019 | 7.50 Mn |
| Sep 30, 2019 | 7.50 Mn |
| Jun 30, 2019 | 7.50 Mn |
| Mar 31, 2019 | 7.50 Mn |
| Dec 31, 2018 | 7.50 Mn |
| Sep 30, 2018 | 6.27 Mn |
| Jun 30, 2018 | 6.96 Mn |
| Mar 31, 2018 | 7.16 Mn |
| Dec 31, 2017 | 7.10 Mn |
| Sep 30, 2017 | 7.04 Mn |
| Jun 30, 2017 | 7.36 Mn |
| Mar 31, 2017 | 7.34 Mn |
| Dec 31, 2016 | 7.32 Mn |
| Sep 30, 2016 | 7.31 Mn |
| Jun 30, 2016 | 7.29 Mn |
| Dec 31, 2015 | 232,000.00 |
| Sep 30, 2015 | 232,000.00 |
| Dec 31, 2014 | 493,000.00 |